Bessemer Group Inc. Reduces Holdings in Agilent Technologies, Inc. $A

Bessemer Group Inc. lessened its position in shares of Agilent Technologies, Inc. (NYSE:A) by 0.8% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 886,587 shares of the medical research company’s stock after selling 7,304 shares during the quarter. Bessemer Group Inc. owned 0.31% of Agilent Technologies worth $104,626,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Verdence Capital Advisors LLC grew its stake in Agilent Technologies by 5.0% during the 2nd quarter. Verdence Capital Advisors LLC now owns 1,818 shares of the medical research company’s stock valued at $215,000 after purchasing an additional 86 shares during the last quarter. Valeo Financial Advisors LLC grew its stake in Agilent Technologies by 3.0% during the 1st quarter. Valeo Financial Advisors LLC now owns 3,449 shares of the medical research company’s stock valued at $403,000 after purchasing an additional 102 shares during the last quarter. Cary Street Partners Financial LLC grew its stake in Agilent Technologies by 2.9% during the 1st quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company’s stock valued at $431,000 after purchasing an additional 103 shares during the last quarter. Stratos Wealth Partners LTD. grew its stake in Agilent Technologies by 0.3% during the 1st quarter. Stratos Wealth Partners LTD. now owns 41,334 shares of the medical research company’s stock valued at $4,835,000 after purchasing an additional 124 shares during the last quarter. Finally, Athena Investment Management grew its stake in Agilent Technologies by 4.5% during the 1st quarter. Athena Investment Management now owns 2,881 shares of the medical research company’s stock valued at $337,000 after purchasing an additional 125 shares during the last quarter.

Wall Street Analysts Forecast Growth

A has been the topic of several research analyst reports. Evercore ISI boosted their price target on Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research note on Tuesday, October 7th. JPMorgan Chase & Co. boosted their price target on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Wells Fargo & Company boosted their price objective on Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a report on Monday, September 15th. Weiss Ratings reissued a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. Finally, Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $149.62.

Agilent Technologies Stock Performance

Shares of A stock opened at $146.82 on Tuesday. The stock has a market cap of $41.62 billion, a PE ratio of 34.47, a price-to-earnings-growth ratio of 4.83 and a beta of 1.26. The business has a 50-day simple moving average of $130.95 and a 200-day simple moving average of $119.71. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.37. The company had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.Agilent Technologies’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were issued a $0.248 dividend. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is presently 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.